Stay updated on Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.5.0 appears on the page, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-25T07:31:53.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and v3.4.2 was removed. This update concerns metadata only and does not alter the study details or user-facing content on the page.
    Difference
    0.0%
    Check dated 2026-03-10T14:57:30.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no substantive changes to the study details or core content observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-17T01:22:07.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1; removed the funding-status notice and the prior Revision: v3.4.0 notice.
    Difference
    0.1%
    Check dated 2026-02-09T23:01:12.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added at the top of the page. The notice states that the NIH Clinical Center is open and directs users to cc.nih.gov and opm.gov for status updates.
    Difference
    0.1%
    Check dated 2026-02-02T20:32:14.000Z thumbnail image
  9. Check
    75 days ago
    Change Detected
    Summary
    Added a glossary toggle (Show glossary) and updated metadata to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed the older lowercase version of the QC note and the previous Revision: v3.3.4 label.
    Difference
    0.1%
    Check dated 2026-01-26T21:02:41.000Z thumbnail image

Stay in the know with updates to Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.